Showing results (1021-1030 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|April 19, 2019
An update on heart disease risk associated with testosterone boosting medicationsG Corona, G Rastrelli, F Guaraldi, et al.Expert Opinion on Drug Safety|September 29, 2018
Optimal management of patients with hepatocellular carcinoma treated with lenvatinibMasafumi Ikeda, Masahiro Kobayashi, Makoto Tahara, et al.Expert Opinion on Drug Safety|April 13, 2019
Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settingsKristy Kummerow Broman, Lesly A Dossett, James Sun, et al.Expert Opinion on Drug Safety|October 5, 2018
The usefulness of listening social media for pharmacovigilance purposes: a systematic reviewIrma Convertino, Sara Ferraro, Corrado Blandizzi, et al.Expert Opinion on Drug Safety|June 23, 2017
Treatment options for nonalcoholic steatohepatitis - a safety evaluationDanny Issa, Julia Wattacheril, Arun J SanyalExpert Opinion on Drug Safety|May 25, 2017
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studiesDaniel Castellano, José Pablo Maroto, Enrique Espinosa, et al.Expert Opinion on Drug Safety|July 6, 2017
The safety of albiglutide for the treatment of type 2 diabetesMarc S RendellExpert Opinion on Drug Safety|July 1, 2017
Safety and benefit considerations for menopausal hormone therapyJames H Pickar, David F Archer, Risa Kagan, et al.Expert Opinion on Drug Safety|August 23, 2016
Progestogen safety and tolerance in hormonal replacement therapySantiago Palacios, Andrea MejíaExpert Opinion on Drug Safety|May 31, 2018
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinibMassimo Breccia, Fabio Efficace, Alessandra Iurlo, et al.Pageof 282